Chantal Hamlin, NP
Nurse Practitioner · Milwaukee, WINPI 1124792015
Payments from drug & device makers
Across 70 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$183
- Takeda Pharmaceuticals U.S.A., Inc.$172
- Vifor Pharma, Inc.$151
- Aurinia Pharma U.S., Inc.$102
- Daiichi Sankyo Inc.$97
- OPKO Pharmaceuticals, LLC$96
- plus $623 from 13 others
What the payments were for
- Food & beverage$1,32893%
- Education$967%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 11 | $183 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $172 |
| Vifor Pharma, Inc. | 7 | $151 |
| Aurinia Pharma U.S., Inc. | 5 | $102 |
| Daiichi Sankyo Inc. | 4 | $97 |
| OPKO Pharmaceuticals, LLC | 5 | $96 |
| GSK | 5 | $94 |
| AstraZeneca(2 entities) | 4 | $87 |
| Mallinckrodt Hospital Products Inc. | 4 | $76 |
| Ultragenyx Pharmaceutical Inc. | 4 | $68 |
| Boehringer Ingelheim | 3 | $60 |
| ANI Pharmaceuticals, Inc. | 2 | $51 |
| Travere Therapeutics, Inc. | 3 | $43 |
| Fresenius USA Marketing, Inc. | 2 | $40 |
| Amicus Therapeutics, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Sanofi | 1 | $21 |
| Calliditas Therapeutics US Inc. | 1 | $21 |
| Bayer | 1 | $18 |
How this compares
$1,424 in reported general payments places this provider in the 90th percentile of 3,478 nurse practitioner providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $62 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Milwaukee
- Trisha WilcoxMilwaukee$174K
- Christina SauldMilwaukee$111K
- Colleen TrevinoMilwaukee$94K
- Kelly FlugaurMilwaukee$38K
- Mathew TilsonMilwaukee$21K
- Mary Elizabeth Nelson-BiersachMilwaukee$18K
- Angela KrausMilwaukee$17K
- Megan LaneMilwaukee$14K
- Heather SandersMilwaukee$13K
- Jennifer NiederstadtMilwaukee$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.